HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Emcure Pharmaceuticals reports 34% rise in Q2 consolidated net profit
Nov-04-2026

Emcure Pharmaceuticals has reported results for the second quarter ended September 30, 2026 (Q2FY27).

The company has reported over two-fold jump in its net profit at Rs 248.43 crore for the quarter ended September 30, 2026 as compared to Rs 117.62 crore for the same quarter in the previous year. The total income of the company has increased by 32.58% at Rs 1,701.52 crore for Q2FY27 as compared to Rs 1,283.36 crore for the corresponding quarter of the previous year.

On consolidated basis, the company has reported 33.73% rise in its net profit at Rs 325.57 crore for the quarter ended September 30, 2026 as compared to Rs 243.46 crore for the same quarter in the previous year. The total income of the company increased by 24.23% at Rs 2,823.73 crore for Q2FY27 as compared to Rs 2,272.95 crore for the corresponding quarter previous year.

  RELATED NEWS >>